Literature DB >> 18440098

Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the sigma1 binding site.

Daniele Zampieri1, Maria Grazia Mamolo, Erik Laurini, Caterina Zanette, Chiara Florio, Simona Collina, Daniela Rossi, Ornella Azzolina, Luciano Vio.   

Abstract

We describe here the synthesis and the binding interaction with sigma(1) and sigma(2) receptors of a series of new benzo[d]oxazol-2(3H)-one derivatives variously substituted on the N-benzyl moiety. The results of binding studies confirm the notion that the benzoxazolone moiety confers preference towards sigma(1) sites and establish that the ability to bind to sigma(1), but not to sigma(2) receptors, is strongly affected by the kind and the position of the substituents introduced in the N-benzyl ring. In fact, compounds with substitutions in para-position with atoms of Cl, H or F or with a CH(3) group exhibit a higher affinity for sigma(1) receptors than the corresponding ortho-substituted compounds. The highest affinity and selectivity, with K(i) values of 0.1 and 427 nM for sigma(1) and sigma(2) receptors, respectively, and a corresponding K(i)sigma(2)/K(i)sigma(1) selectivity ratio of 4270 were found for the Cl-substituted compound. These results indicate that benzo[d]oxazol-2(3H)-one derivatives are among the most selective and sigma(1) receptor-preferring ligands currently available.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18440098     DOI: 10.1016/j.ejmech.2008.03.011

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

1.  Homology Model and Docking-Based Virtual Screening for Ligands of the σ1 Receptor.

Authors:  Erik Laurini; Valentina Dal Col; Maria Grazia Mamolo; Daniele Zampieri; Paola Posocco; Maurizio Fermeglia; Luciano Vio; Sabrina Pricl
Journal:  ACS Med Chem Lett       Date:  2011-08-27       Impact factor: 4.345

2.  Synthesis and characterization of [³H]-SN56, a novel radioligand for the σ₁ receptor.

Authors:  James A Fishback; Christophe Mesangeau; Jacques H Poupaert; Christopher R McCurdy; Rae R Matsumoto
Journal:  Eur J Pharmacol       Date:  2010-12-02       Impact factor: 4.432

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.